Adding To My Barrick Position On Long-Term Gold Prospects And Diversification Into Copper
Barrick's share price has lagged gold's rise, but I am buying on pullbacks and selling rallies, trading around a core position for long-term potential. The main reason why its share price failed to match the rise in gold prices is that Barrick failed to capitalize on it by increasing profits accordingly. Barrick is evolving into a gold and copper producer, with copper driving most future growth, especially after 2028, with the Reko Diq mine.
Gold (XAUUSD) & Silver Price Forecast: XAU Eyes $3,340 Breakout, XAG Clings to Support
Gold prices steady near $3,322 amid Fed rate cut expectations, a weaker USD, and geopolitical risks shaping cautious sentiment.
Gold Edges Higher Amid Geopolitical Tensions
Gold edged higher in the early Asian session. For this week, geopolitical tensions will likely continue to lead safe-haven buying, Angel One said.
U.S. sanctions push global powers toward gold-backed alternatives - Atlantic Council
Neils Christensen has a diploma in journalism from Lethbridge College and has more than a decade of reporting experience working for news organizations throughout Canada. His experiences include covering territorial and federal politics in Nunavut, Canada.
Surefire Resources launches $3.9 million capital raise to advance WA gold and copper projects
Surefire Resources NL has kicked off a non-renounceable entitlement offer aiming to raise up to $3.88 million to progress its Yidby Gold and Copper Hill projects in Western Australia and continue exploration across its broader portfolio. The offer entitles eligible shareholders to subscribe for two new fully paid ordinary shares for every three shares held as of the record date of May 29, at an issue price of $0.002 per share.
Gold Edges Lower After Trump Agrees to Delay New EU Tariffs
Gold edged lower in the early Asian session after President Trump said on Sunday that he agreed to delay new EU tariffs.
Sona Nanotech advances toward first-in-human gold nanorod trial - ICYMI
Sona Nanotech Inc (CSE:SONA, OTCQB:SNANF) chief medical officer Dr Carman Giacomantonio joined Proactive to discuss a critical development in the company's gold nanorod cancer therapy. Dr Giacomantonio talked about the company's progress as it moves toward its first-in-human clinical trial for patients with melanoma that has not responded to standard immunotherapy.
Hang Seng Index: Gains on PBoC Rate Cut and Easing Trade Tensions – Weekly Recap
Hang Seng extends gains amid PBoC rate cuts, easing US-China tensions, and tech earnings misses. Trade, debt, and policy risks stay in focus.
Don't tell the ECB, but gold shines as faith in global bonds wavers
Neils Christensen has a diploma in journalism from Lethbridge College and has more than a decade of reporting experience working for news organizations throughout Canada. His experiences include covering territorial and federal politics in Nunavut, Canada.
Platinum Gets a Glimmer of Hope. But Gold Still Rules.
For a decade or so, gold prices have been at a big premium to platinum. But with platinum demand strong and supply down, investors in the silver metal are having a bullish moment.
Wall Street goes full bull on gold, Main Street reclaims bullish bias as gold holds above $3,300/oz
Ernest Hoffman is a Crypto and Market Reporter for Kitco News. He has over 15 years of experience as a writer, editor, broadcaster and producer for media, educational and cultural organizations.
Will gold be the last safe-haven standing next week?
Neils Christensen has a diploma in journalism from Lethbridge College and has more than a decade of reporting experience working for news organizations throughout Canada. His experiences include covering territorial and federal politics in Nunavut, Canada.
